Strengthening the capability of non-tuberculosis-designated medical institutions to improve the diagnosis of tuberculosis

doi:10.19982/j.issn.1000-6621.20230001

Abstract

Abstract:

Tuberculosis remains a major public health problem worldwide. The epidemic of novel coronavirus infection (COVID-19) has negative impact on the prevention and treatment of global tuberculosis, the dual challenges of both traditional and emerging respiratory infectious diseases need to be dealt with. There are many problems in the prevention and control of tuberculosis in non-tuberculosis-designated medical institutions. Under the new situation, as a country with high burden of tuberculosis, China needs to improve the diagnosis of tuberculosis in non-tuberculosis-designated medical institutions from various aspects.

Key words: Hospitals, general, Tuberculosis, Diagnosis

CLC Number:

R52
R318.13

Liao Yixuan, Fang Chuangsen, Li Yanming. Strengthening the capability of non-tuberculosis-designated medical institutions to improve the diagnosis of tuberculosis[J]. Chinese Journal of Antituberculosis, 2023, 45(5): 437-441. doi: 10.19982/j.issn.1000-6621.20230001

References 28

[1]	World Health Organization.Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
[2]	Dean AS, Tosas Auguet O, Glaziou P, et al. 25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward. Lancet Infect Dis, 2022, 22(7): e191-e196. doi:10.1016/S1473-3099(21)00808-2. doi: 10.1016/S1473-3099(21)00808-2 pmid: 35248168
[3]	Dheda K, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med, 2022, 10(6): 603-622. doi:10.1016/S2213-2600(22)00092-3. doi: 10.1016/S2213-2600(22)00092-3 pmid: 35338841
[4]	Long Q, Guo L, Jiang W, et al. Ending tuberculosis in China: health system challenges. Lancet Public Health, 2021, 6(12): e948-e953. doi:10.1016/S2468-2667(21)00203-6. doi: 10.1016/S2468-2667(21)00203-6 pmid: 34838198
[5]	中华人民共和国卫生部疾病预防控制局, 中国疾病预防控制中心. 全国第五次结核病流行病学抽样调查资料. 北京: 军事医学科学出版社, 2011.
[6]	国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知. 国办发〔2017〕16号. 2017-02-01.
[7]	Du X, Li T, Liu X, et al. Health Facilities and Treatment Service Models of the National Tuberculosis Program-China, 2010—2020. China CDC Wkly, 2021, 3(13): 274-278. doi:10.46234/ccdcw2021.071. doi: 10.46234/ccdcw2021.071
[8]	中华人民共和国国家卫生健康委员会.2021中国卫生健康统计年鉴. 北京: 中国协和医科大学出版社, 2021.
[9]	Teo AKJ, Singh SR, Prem K, et al. Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis. Respir Res, 2021, 22(1): 251. doi:10.1186/s12931-021-01841-6. doi: 10.1186/s12931-021-01841-6
[10]	中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 中华人民共和国教育部, 等. 卫生健康委发展改革委教育部科技部民政部财政部扶贫办医保局关于印发遏制结核病行动计划(2019—2022年)的通知. 国卫疾控发〔2019〕41号. 2019-05-31.
[11]	潘玮, 李伟, 郝春霞, 等. 三级综合医院门急诊护士结核病防控核心信息知晓率的调查分析. 循证护理, 2021, 7(2):276-280. doi:10.12102/j.issn.2095-8668.2021.02.030. doi: 10.12102/j.issn.2095-8668.2021.02.030
[12]	国家呼吸医疗质量控制中心.2021年国家医疗服务与质量安全报告: 呼吸专业分册. 北京: 科学技术文献出版社, 2022.
[13]	Zhang L, Weng TP, Wang HY, et al. Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in China. Clin Microbiol Infect, 2021, 27(7): 1000-1006. doi:10.1016/j.cmi.2020.12.031. doi: 10.1016/j.cmi.2020.12.031 URL
[14]	Jiang Y, Cao B, Ohmagari N, et al. Comprehensive understanding of health-seeking behaviour among pulmonary tuberculosis patients in China. Int J Tuberc Lung Dis, 2017, 21(10): 1094-1099. doi:10.5588/ijtld.17.0227. doi: 10.5588/ijtld.17.0227 pmid: 28911351
[15]	Kang W, Yu J, Du J, et al. The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study. PLoS One, 2020, 15(8): e0237753. doi:10.1371/journal.pone.0237753. doi: 10.1371/journal.pone.0237753 URL
[16]	高丽, 庞学文, 万莹, 等. 天津市综合医疗机构在四种高危人群中开展结核病确诊相关检查现况调查. 中国防痨杂志, 2022, 44(4):397-402. doi:10.19982/j.issn.1000-6621.20220018. doi: 10.19982/j.issn.1000-6621.20220018
[17]	中华人民共和国国家卫生健康委临床检验中心.2022年临床检验室间质量评价计划. 北京: 中华人民共和国国家卫生健康委临床检验中心, 2022.
[18]	高伊来, 包淑媚, 章莉丽. 采取干预措施对临床医生肺结核主动报卡率的对照探析. 中国卫生产业, 2019, 16(16):157-158,161. doi:10.16659/j.cnki.1672-5654.2019.16.157. doi: 10.16659/j.cnki.1672-5654.2019.16.157
[19]	苏琼, 成经芸. 三甲综合医院肺结核转诊到位率情况分析及应对措施. 现代医院, 2021, 21(7):1086-1088,1092. doi:10.3969/j.issn.1671-332X.2021.07.031. doi: 10.3969/j.issn.1671-332X.2021.07.031
[20]	郭华征, 邢振川. 北京市某综合医院呼吸科病房肺结核患者特征及转诊情况分析. 结核与肺部疾病杂志, 2022, 3(2):110-117. doi:10.19983/j.issn.2096-8493.20210152. doi: 10.19983/j.issn.2096-8493.20210152
[21]	王艳, 洪创跃, 房宏霞, 等. 综合医疗机构呼吸科住院患者结核病筛查的研究. 中华结核和呼吸杂志, 2022, 45(12):1209-1213. doi:10.3760/cma.j.cn112147-20220720-00613. doi: 10.3760/cma.j.cn112147-20220720-00613
[22]	张灿有, 陈卉, 法立峰, 等. 2016—2019年结核感染控制培训班培训效果评价. 中国防痨杂志, 2022, 44(2):174-180. doi:10.19982/j.issn.1000-6621.20210544. doi: 10.19982/j.issn.1000-6621.20210544
[23]	Wu S, Li R, Su W, et al. Is knowledge retained by healthcare providers after training? A pragmatic evaluation of drug-resistant tuberculosis management in China. BMJ Open, 2019, 9(3): e024196. doi:10.1136/bmjopen-2018-024196. doi: 10.1136/bmjopen-2018-024196 URL
[24]	Cole B, Nilsen DM, Will L, et al. Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association. MMWR Recomm Rep, 2020, 69(7): 1-27. doi:10.15585/mmwr.rr6907a1. doi: 10.15585/mmwr.rr6907a1 pmid: 32730235
[25]	崔晓敬, 魏栋, 王春雷, 等. 分子生物学和液体培养方法提高综合医院结核病病原学诊断能力的价值. 中国防痨杂志, 2021, 43(2):143-146. doi:10.3969/j.issn.1000-6621.2021.02.008. doi: 10.3969/j.issn.1000-6621.2021.02.008
[26]	Casela M, Cerqueira SMA, Casela TO, et al. Rapid molecular test for tuberculosis: impact of its routine use at a referral hospital. J Bras Pneumol, 2018, 44(2): 112-117. doi:10.1590/s1806-37562017000000201. doi: S1806-37132018000200112 pmid: 29791546
[27]	中国医疗保健国际交流促进会临床微生物与感染分会, 中华医学会检验医学分会临床微生物学组, 中华医学会微生物学和免疫学分会临床微生物学组. 综合医院结核分枝杆菌感染实验室检查共识. 中华检验医学杂志, 2022, 45(4):343-353. doi:10.3760/cma.j.cn114452-20211118-00722. doi: 10.3760/cma.j.cn114452-20211118-00722
[28]	Agins BD, Ikeda DJ, Reid MJA, et al. Improving the cascade of global tuberculosis care: moving from the “what” to the “how” of quality improvement. Lancet Infect Dis, 2019, 19(12): e437-e443. doi:10.1016/S1473-3099(19)30420-7. doi: 10.1016/S1473-3099(19)30420-7 URL